Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 20, 2006

QLT Earmarks $1.45M for AMD Research at Wilmer Eye Institute

  • QLT will research and develop potential treatments for dry age-related macular degeneration (AMD), under a two-year research collaboration and option agreement with the Wilmer Eye Institute at Johns Hopkins University.

    The agreement provides QLT with the first option to negotiate an exclusive license to patented products resulting from the research that could ultimately prevent the production and accumulation of toxic lipids in the eye that are believed to be key early events in dry AMD.

    Under the terms of the agreement, Johns Hopkins University will receive $1.45 million in research funding over two years. If QLT exercises its license option, it will pay Johns Hopkins certain financial milestones and royalties.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »